|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
The Protein-Retaining Effects of Growth Hormone During Fasting Involve Inhibition of Muscle-Protein Breakdown
From Medical Department M (Endocrinology and Diabetes) (H.N., J.O.L.J., J.S.C., N.M.), Aarhus Kommunehospital, Aarhus, Denmark; and the Endocrinology Division (K.S.N.), Mayo Clinic, Rochester, Minnesota.
Address correspondence and reprint requests to: Helene Nørrelund, Medical Department M, Aarhus Kommunehospital, DK-8000 Aarhus C, Denmark. E-mail: helenenorrelund{at}dadlnet.dk .
The metabolic response to fasting involves a series of hormonal and metabolic adaptations leading to protein conservation. An increase in the serum level of growth hormone (GH) during fasting has been well substantiated. The present study was designed to test the hypothesis that GH may be a principal mediator of protein conservation during fasting and to assess the underlying mechanisms. Eight normal subjects were examined on four occasions: 1) in the basal postabsorptive state (basal), 2) after 40 h of fasting (fast), 3) after 40 h of fasting with somatostatin suppression of GH (fast-GH), and 4) after 40 h of fasting with suppression of GH and exogenous GH replacement (fast+GH). The two somatostatin experiments were identical in terms of hormone replacement (except for GH), meaning that somatostatin, insulin, glucagon and GH were administered for 28 h; during the last 4 h, substrate metabolism was investigated. Compared with the GH administration protocol, IGF-I and free IGF-I decreased 35 and 70%, respectively, during fasting without GH. Urinary urea excretion and serum urea increased when participants fasted without GH (urea excretion: basal 392 ± 44, fast 440 ± 32, fast-GH 609 ± 76, and fast+GH 408 ± 36 mmol/24 h, P < 0.05; serum urea: basal 4.6 ± 0.1, fast 6.2 ± 0.1, fast-GH 7.0 ± 0.2, and fast+GH 4.3 ± 0.2 mmol/l, P < 0.01). There was a net release of phenylalanine across the forearm, and the negative phenylalanine balance was higher during fasting with GH suppression (balance: basal 9 ± 3, fast 15 ± 6, fast-GH 17 ± 4, and fast+GH 11 ± 5 nmol/min, P < 0.05). Muscle-protein breakdown was increased among participants who fasted without GH (phenylalanine rate of appearance: basal 17 ± 4, fast 26 ± 9, fast-GH 33 ± 7, fast+GH 25 ± 6 nmol/min, P < 0.05). Levels of free fatty acids and oxidation of lipid decreased during fasting without GH (P < 0.01). In summary, we find that suppression of GH during fasting leads to a 50% increase in urea-nitrogen excretion, together with an increased net release and appearance rate of phenylalanine across the forearm. These results demonstrate that GH—possibly by maintenance of circulating concentrations of free IGF-I—is a decisive component of protein conservation during fasting and provide evidence that the underlying mechanism involves a decrease in muscle protein breakdown.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Feldt-Rasmussen, M. Lange, W. Sulowicz, U. Gafter, K. N. Lai, J. Wiedemann, J. S. Christiansen, M. El Nahas, and and the Adult Patients in Chronic Dialysis (APCD) Growth Hormone Treatment during Hemodialysis in a Randomized Trial Improves Nutrition, Quality of Life, and Cardiovascular Risk J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2161 - 2171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Gormsen, N. Jessen, J. Gjedsted, S. Gjedde, H. Norrelund, S. Lund, J. S. Christiansen, S. Nielsen, O. Schmitz, and N. Moller Dose-Response Effects of Free Fatty Acids on Glucose and Lipid Metabolism during Somatostatin Blockade of Growth Hormone and Insulin in Humans J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1834 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Jessen, C. B. Djurhuus, J. O. L. Jorgensen, L. S. Jensen, N. Moller, S. Lund, and O. Schmitz Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E194 - E199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Kanaley, R. Dall, N. Moller, S. C. Nielsen, J. S. Christiansen, M. D. Jensen, and J. O. L. Jorgensen Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men J Appl Physiol, February 1, 2004; 96(2): 747 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Norrelund, C. Djurhuus, J. O. L. Jorgensen, S. Nielsen, K. S. Nair, O. Schmitz, J. S. Christiansen, and N. Moller Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E737 - E743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Norrelund, K. S. Nair, S. Nielsen, J. Frystyk, P. Ivarsen, J. O. L. Jorgensen, J. S. Christiansen, and N. Moller The Decisive Role of Free Fatty Acids for Protein Conservation during Fasting in Humans with and without Growth Hormone J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4371 - 4378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Buijs, J. A. Romijn, J. Burggraaf, M. L. de Kam, A. F. Cohen, M. Frolich, F. Stellaard, A. E. Meinders, and H. Pijl Growth Hormone Blunts Protein Oxidation and Promotes Protein Turnover to a Similar Extent in Abdominally Obese and Normal-Weight Women J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5668 - 5674. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |